Form CORRESP - Correspondence:
SEC Accession No. 0001493152-20-021708
Filing Date
2020-11-16
Accepted
2020-11-16 16:35:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 14082
  Complete submission text file 0001493152-20-021708.txt   15073
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations